Tanaka A - Search Results

1

Effect of deferred or no treatment with ursodeoxycholic acid in patients with early primary biliary cholangitis.

Tanaka A, Hirohara J, Nakano T, Yagi M, Namisaki T, Yoshiji H, Nakanuma Y, Takikawa H; Japan PBC Study Group (JPBCSG). Tanaka A, et al. Hepatol Res. 2018 Aug;48(9):727-734. doi: 10.1111/hepr.13068. Epub 2018 Mar 7. Hepatol Res. 2018. PMID: 29405510

2

Eta-1/osteopontin genetic polymorphism and primary biliary cirrhosis.

Kikuchi K, Tanaka A, Miyakawa H, Kawashima Y, Kawaguchi N, Matsushita M, Gershwin ME. Kikuchi K, et al. Among authors: tanaka a. Hepatol Res. 2003 Jun;26(2):87-90. doi: 10.1016/s1386-6346(03)00012-3. Hepatol Res. 2003. PMID: 12809934

3

The clinical significance of IgA antimitochondrial antibodies in sera and saliva in primary biliary cirrhosis.

Tanaka A, Nezu S, Uegaki S, Mikami M, Okuyama S, Kawamura N, Aiso M, Gershwin ME, Takahashi S, Selmi C, Takikawa H. Tanaka A, et al. Ann N Y Acad Sci. 2007 Jun;1107:259-70. doi: 10.1196/annals.1381.028. Ann N Y Acad Sci. 2007. PMID: 17804554

4

Hepatic steatosis as a possible risk factor for the development of hepatocellular carcinoma after eradication of hepatitis C virus with antiviral therapy in patients with chronic hepatitis C.

Tanaka A, Uegaki S, Kurihara H, Aida K, Mikami M, Nagashima I, Shiga J, Takikawa H. Tanaka A, et al. World J Gastroenterol. 2007 Oct 21;13(39):5180-7. doi: 10.3748/wjg.v13.i39.5180. World J Gastroenterol. 2007. PMID: 17876888 Free PMC article.

5

Gene expression profiling in whole liver of bile duct ligated rats: VEGF-A expression is up-regulated in hepatocytes adjacent to the portal tracts.

Tanaka A, Tsuneyama K, Mikami M, Uegaki S, Aiso M, Takikawa H. Tanaka A, et al. J Gastroenterol Hepatol. 2007 Nov;22(11):1993-2000. doi: 10.1111/j.1440-1746.2006.04629.x. J Gastroenterol Hepatol. 2007. PMID: 17914982

6

Genetic background of primary biliary cirrhosis.

Tanaka A. Tanaka A. Hepatol Res. 2007 Oct;37 Suppl 3:S377-83. doi: 10.1111/j.1872-034X.2007.00242.x. Hepatol Res. 2007. PMID: 17931190

7

Successful treatment with colestimide for a bout of cholestasis in a Japanese patient with benign recurrent intrahepatic cholestasis caused by ATP8B1 mutation.

Uegaki S, Tanaka A, Mori Y, Kodama H, Fukusato T, Takikawa H. Uegaki S, et al. Among authors: tanaka a. Intern Med. 2008;47(7):599-602. doi: 10.2169/internalmedicine.47.0534. Epub 2008 Apr 1. Intern Med. 2008. PMID: 18379143 Free article.

8

Outcome and prognostic factors of 391 Japanese patients with primary sclerosing cholangitis.

Tanaka A, Takamori Y, Toda G, Ohnishi S, Takikawa H. Tanaka A, et al. Liver Int. 2008 Aug;28(7):983-9. doi: 10.1111/j.1478-3231.2008.01726.x. Epub 2008 Apr 7. Liver Int. 2008. PMID: 18397233

9

Vitamin D receptor polymorphisms are associated with increased susceptibility to primary biliary cirrhosis in Japanese and Italian populations.

Tanaka A, Nezu S, Uegaki S, Kikuchi K, Shibuya A, Miyakawa H, Takahashi S, Bianchi I, Zermiani P, Podda M, Ohira H, Invernizzi P, Takikawa H. Tanaka A, et al. J Hepatol. 2009 Jun;50(6):1202-9. doi: 10.1016/j.jhep.2009.01.015. Epub 2009 Mar 5. J Hepatol. 2009. PMID: 19376604

10

Urinary bile acid sulfate levels in patients with hepatitis C virus-related chronic liver diseases.

Negoro S, Tanaka A, Takikawa H. Negoro S, et al. Among authors: tanaka a. Hepatol Res. 2009 Aug;39(8):760-5. doi: 10.1111/j.1872-034X.2009.00516.x. Epub 2009 Apr 3. Hepatol Res. 2009. PMID: 19473428

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,415 results

Search Page

Filters